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Abstract
Background: Three transcription factors that are expressed at high levels in embryonic stem cells
(ESCs) are Nanog, Oct-4 and Sox-2. These transcription factors regulate the expression of other
genes during development and are found at high levels in the pluripotent cells of the inner cell mass.
The downregulation of these three transcription factors correlates with the loss of pluripotency
and self-renewal, and the beginning of subsequent differentiation steps. The roles of Nanog, Oct-4
and Sox-2 have not been fully elucidated. They are important in embryonic development and
maintenance of pluripotency in ESCs. We studied the expression of these transcription factors in
porcine umbilical cord (PUC) matrix cells.
Methods:  Cells were isolated from Wharton's jelly of porcine umbilical cords (PUC) and
histochemically assayed for the presence of alkaline phosphatase and the presence of Nanog, Oct-
4 and Sox-2 mRNA and protein. PCR amplicons were sequenced and compared with known
sequences. The synthesis of Oct-4 and Nanog protein was analyzed using immunocytochemistry.
FACS analysis was utilized to evaluate Hoechst 33342 dye-stained cells.
Results: PUC isolates were maintained in culture and formed colonies that express alkaline
phosphatase. FACS analysis revealed a side population of Hoechst dye-excluding cells, the Hoechst
exclusion was verapamil sensitive. Quantitative and non-quantitative RT-PCR reactions revealed
expression of Nanog, Oct-4 and Sox-2 in day 15 embryonic discs, PUC cell isolates and porcine
fibroblasts. Immunocytochemical analysis detected Nanog immunoreactivity in PUC cell nuclei, and
faint labeling in fibroblasts. Oct-4 immunoreactivity was detected in the nuclei of some PUC cells,
but not in fibroblasts.
Conclusion: Cells isolated from PUC express three transcription factors found in pluripotent
stem cell markers both at the mRNA and protein level. The presence of these transcription factors,
along with the other characteristics of PUC cells such as their colony-forming ability, Hoechst dye-
excluding side population and alkaline phosphatase expression, suggests that PUC cells have
properties of primitive pluripotent stem cells. Furthermore, PUC cells are an easily and
inexpensively obtained source of stem cells that are not hampered by the ethical or legal issues
associated with ESCs. In addition, these cells can be cryogenically stored and expanded.
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Background
Stem cells constitute a population of cells that are present
in all stages of development from preimplantation
embryos through adulthood. Pluripotent stem cells have
the ability to self-renew for indefinite periods in culture
and to differentiate, e.g., give rise to all of the specialized
cells in an animal. Currently, pluripotent stem cells can be
isolated consistently only from the inner cell mass of
embryos or from the gonadal ridge [1]. In contrast,
multipotent stem cells have the ability to self-renew and
to differentiate into two of the three germ layers; this type
of cell has been isolated from adult animals [2]. It would
be advantageous to have a readily available, low cost
source of stem cells in large animal species to facilitate
biotechnology, since embryonic stem cells (ESCs) are
problematic.
Three transcription factors found in mouse and human
ESCs play a central role in the regulation of pluripotency
and self-renewal. These factors include the POU (Pit/Oct/
Unc) domain-containing protein Oct-4 [3-5], Sox-2 [6]
and the homeoprotein Nanog [7,8]. All three transcrip-
tion factors are expressed in high levels in pluripotent cells
and are considered markers of primitive stem cells. The
conservation of these three transcription factors across
mammalian species is becoming apparent. A recent report
suggests that they work in a cooperative fashion to regu-
late many genes [9].
ESCs, derived from the inner cell mass, and primordial or
embryonic germ cells (EGCs), derived from the gonadal
ridge, are two examples of pluripotent stem cells. Stem
cells with more restricted differentiation potential have
been isolated from most postnatal tissues. Postnatal
sources of stem cells include bone marrow [10], umbilical
cord blood [11-13], vasculature or perivascular space [14-
16], placental tissue [17,18] amniotic fluid [19], adipose
tissue [20] and skin [21]. In general, Oct-4, Sox-2 and
Nanog are not highly expressed in these stem cells and
they are not thought to be pluripotent. While stem cells
from these sources are not pluripotent or immortal, tech-
nical considerations such as ease of collection, collection
of a large number of cells, collection for autologous trans-
plantation, and ethical considerations such as collection
with informed consent, are important counterpoints. For
stem cell applications in biotechnology and agriculture,
the ability to collect large number of cells, the collection
of cells inexpensively and non-invasively, without risk to
the donor, and the ability to cryogenically bank and
expand the cells in vitro are important considerations.
Therapeutically, stem cells from non-embryonic sources
have been used clinically and have successfully treated a
number of diseases. To advance animal biotechnology, it
will be necessary to produce ESCs and EGCs that display
germ line transmission in species other than the mouse;
so far this has not met with success [22].
The stem cell population in Wharton's jelly of the umbil-
ical cord has properties that make it of interest [23-26].
For example, it is simple to harvest by non-invasive
means, provides large numbers of cells without risk to the
donor, the stem cell population may be expanded in vitro,
cryogenically stored, thawed, expanded, genetically
manipulated and differentiated in vitro [24]. The umbili-
cal cord forms early during gestation, and it encloses the
yolk sac, which is the embryologic source of both primor-
dial germ cells and the first hematopoietic stem cells.
Importantly, the umbilical cord's physiological functions
end at parturition. This structure is embryonic in origin
and harvested after birth. The umbilical cord Wharton's
Jelly and the umbilical cord blood are non-controversial
sources of primitive stem cells that can be collected and
stored after birth for therapeutic uses or biotechnology.
Here, we characterize umbilical cord Wharton's Jelly stem
cells (called umbilical cord matrix cells) collected from
pig. The pig is a useful target for stem cell technology for
biomedical models for humans [27] and for agricultural
applications. Previously, we showed that after exposure to
differentiation signals, cells derived from human or por-
cine umbilical cord matrix are capable of expressing the
morphology and markers of neural cells, and the undiffer-
entiated cells express a variety of characteristics indicative
of stem cells, for example, telomerase [24]. Here, we
extend that characterization by examining the expression
of the transcription factors Nanog, Oct-4 and Sox-2. These
factors are of central importance to pluripotency and self-
renewal in mouse and human embryonic stem cells [3-8].
In addition, several other characteristics of stem cells are
evaluated.
Materials and methods
Umbilical cord acquisition and cell procurement
All experimental protocols were approved by the Kansas
State University Institutional Care and Use Committee
(IACUC #2164). Umbilical cords were collected from
newborn (term) or mid-gestation (50–55 days post-con-
ception), male and female pigs obtained from the Kansas
State University swine farm. Term umbilical cords were
collected immediately after birth and placed in sterile
0.9% saline or Ringer solution (composition in mM: 120
NaCl 25 NaHCO3, 3.3 KH2PO4, 0.83 K2HPO4, 1.2 CaCl2
and 1.2 MgCl2) and transported to the laboratory at room
temperature. Mid-gestation fetuses and day 14–15 poste-
strus embryonic discs were collected from sows under
general anesthesia using standard veterinary procedures.
Once in the laboratory, the cords were rinsed in sterile
phosphate buffered saline (PBS, composition in mM: 140
NaCl; 2 KCl; 1.5 KH2PO4; 15 Na2HPO4), supplementedReproductive Biology and Endocrinology 2006, 4:8 http://www.rbej.com/content/4/1/8
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with 4 µg/ml amphotericin B, 20 µg/ml gentamicin, 100
U/ml penicillin, and 100 µg/ml streptomycin and placed
in a sterile petri dish for further processing. Umbilical
cord segments 1–3 cm in length were cut longitudinally to
expose the two umbilical arteries and the umbilical vein.
The vessels were removed and discarded. The remaining
umbilical cord tissue including the Wharton's jelly was
diced into 2–5 mm3  explants using single edge razor
blades, transferred to 6-well tissue culture plates (Corning
Inc., Corning, NY) containing 2 ml of cell culture medium
(56% DMEM (low glucose, Gibco-Invitrogen Corpora-
tion, Carlsbad, CA), 37% MCDB 201 (Sigma-Aldrich, Inc.,
St. Louis, MO), 2% fetal bovine serum (FBS, Atlanta Bio-
logicals, Lawrenceville, GA); remaining 5%: 1× insulin-
transferrin-selenium supplement (ITS, Sigma-Aldrich,
Inc.), 1.5 mg/ml AlbuMax I (Gibco-Invitrogen Corp.), 1
nM dexamethasone (Sigma-Aldrich), 100 µM ascorbic
acid 2-phosphate (Sigma-Aldrich, Inc.), 100 U/ml penicil-
lin, 100 µg/ml streptomycin, 0.25 µg/ml amphotericin B
(Gibco-Invitrogen), 10 ng/ml recombinant human epi-
dermal growth factor (EGF, R&D Systems, Minneapolis,
MN), 10 ng/ml rat platelet-derived growth factor (PDGF,
R&D Systems)) and maintained in a 37°C incubator with
a 5% CO2 atmosphere and saturated humidity. Adherent
porcine umbilical cord (PUC) cells were observed 24–48
hrs after plating. Tissue explants were removed from cul-
ture and the remaining adhered PUC cells were dissoci-
ated with 0.1% trypsin + 1.0 mM EDTA in PBS (trypsin/
EDTA, Gibco-Invitrogen) for 3 min. Cells that had
detached in this time were subcultured to a new flask at a
ratio of 1:5 (denoted passage 1) and the remaining cells
were discarded. From this preparation PUC cells were
maintained in culture and periodically subcultured,
seeded onto coverslips for immunocytochemical analysis,
or processed for RNA isolation. For long-term storage,
PUC cells were also cryopreserved in a freezing medium
consisting of 93% FBS and 7% dimethyl sulfoxide
(DMSO, Sigma-Aldrich, Inc.). Early results of the experi-
ments described here from frozen and fresh cells were
indistinguishable. Thus, no distinction was made between
freshly isolated or frozen PUC cells. Furthermore, no com-
parisons between PUC cell isolates derived from the two
sexes or isolates derived from term or mid-gestation
umbilical cord were conducted.
As a control primary cell, fibroblasts were isolated from a
3–4 month old male pig immediately postmortem. The
exterior of one ear was thoroughly cleaned with 70% eth-
anol and ~1 cm2 of skin was excised along with underlying
connective tissue using a sterile scalpel blade and placed
in sterile PBS. Small pieces of subdermis were placed in 6
well tissue culture plates with 2 ml of growth medium per
well and allowed to proliferate. Growth medium con-
sisted of high glucose DMEM (Gibco-Invitrogen) supple-
mented with 10% FBS, 100 U/ml penicillin and 100 µg/
ml streptomycin. Explants were removed within 3 days
and the proliferating fibroblasts were allowed to reach
confluency. Primary cultures were then processed for
immunocytochemistry or RNA isolation as described
below.
Alkaline phosphatase detection
PUC cells from various isolations and passage numbers
were grown on glass coverslips or directly on 12 well tis-
sue culture plates for 2–3 weeks. The medium was
refreshed every 48 hours. Alkaline phosphatase activity
was detected using an Alkaline Phosphatase Substrate Kit
(Vector Laboratories, Burlingame, CA) according to the
manufacturer's instructions. A blue reaction product fol-
lowing 20 minutes of exposure confirmed alkaline phos-
phatase activity. Specificity was verified by including 3 µM
levamisole (an inhibitor of most forms of alkaline phos-
phatase) in the substrate solution prior to cell exposure.
Cells were then fixed in 4% paraformaldehyde, mounted
in DPX (Sigma-Aldrich, Inc.) and photographed using a
Nikon CoolPix digital camera (Nikon, Melville, NY) or a
QImaging Retiga 1300 digital CCD camera (Roper Indus-
tries, Duluth, GA). Images were processed for publication
using CorelDRAW (version 10.0) and/or Paint Shop Pro
(version 5.01, Corel Corporation, Ottawa, Ontario, Can-
ada).
Hoechst dye exclusion and flow cytometry
Frozen PUC cells from four different donors (all between
passage 5 and 10) were thawed and allowed to grow on 25
cm2 tissue culture flasks until colony formation occurred
(1–2 weeks). PUC cells were dissociated in trypsin/EDTA,
pelleted by centrifugation, resuspended at approximately
106 cells/ml in growth medium, and divided into two 1.5
ml microcentrifuge tubes (a small portion of each isola-
tion was reserved for flow sorter calibration). Each tube
was incubated with 2.5 µg/ml Hoechst 33342 (Sigma-
Aldrich, Inc.) at 37°C with or without 50 µM verapamil
(an inhibitor of multi-drug resistance proteins; Sigma-
Aldrich, Inc.) for 90 minutes with intermittent mixing.
After incubation, cells were pelleted and rinsed twice in
ice-cold Hank's Balanced Salt Solution with 2% FBS
(HBSS+FBS; Composition in mM: 137 NaCl; 5.4 KCl; 0.4
KH2PO4; 0.6 Na2HPO4; 5.5 glucose). Propidium iodide
(Sigma-Aldrich, Inc.) was added at 2 µg/ml immediately
prior to analysis to detect dead cells. Fluorescence detec-
tion was conducted on a FACSVantage SE flow cytometer
(BD Biosciences, San Jose, CA) by counting 10,000–
40,000 events. The dyes were excited using an ultra violet
laser and fluorescence was measured using 485/22 and
660/20 dichroic bandpass filters. Experiments were per-
formed two times with multiple observations in each run.
In a separate experiment, cultured porcine fibroblasts
were analyzed using the same protocol. Data were ana-
lyzed using WinMDI software (version 2.8; ScrippsReproductive Biology and Endocrinology 2006, 4:8 http://www.rbej.com/content/4/1/8
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Research Institute, La Jolla, CA). Statistical analysis was
conducted to evaluate the effect of verapamil on the per-
centage of cells with low dye uptake (Hoechstlow cells)
using a t-test following log transformation of the data. The
hypothesis was that verapamil would decrease the % of
PUC cells that were Hoechstlow. A probability for a type I
error of 0.05 (p = 0.05) was considered to be statistically
significant.
RNA isolation, RT-PCR and quantitative RT-PCR
Total RNA was collected from PUC isolations after 1–3
weeks in culture, using an RNeasy Mini Kit (Qiagen,
Valencia, CA). Briefly, PUC cells were exposed to a lysis
buffer supplied with the kit and transferred to the RNeasy
column. A DNase step (RNase-free DNase Set, Qiagen)
was performed to remove genomic DNA. Following
appropriate washings, RNA was eluted from the column
in 20–30 µl nuclease-free water. RNA was also isolated
from embryonic discs (day 14–15 postestrus, two isolates
of 3 pooled discs) and cultured porcine fibroblasts (two
isolates) using the same protocol. Expression of various
stem cell markers was assessed using a OneStep RT-PCR
kit (Qiagen) and gene specific primers. Primers for Sox-2
were designed based on highly homologous regions of
human, mouse, bovine and/or sheep sequences (due to
lack of porcine sequence at the time). Primers were
designed using DNASTAR Primer Select (Macintosh ver-
sion 4.0; DNASTAR, Inc., Madison, WI) or the web-based
Primer3 program [28]. These included Sox-2 (FWD: 5'-
GCCTGGGCGCCGAGTGGA-3'; REV: 5'-
GGGCGAGCCGTTCATGTAGGTCTG-3'; annealing tem-
perature = 64°C, expected product length = 443 bp [Gen-
bank: NM_003106]) and Nanog (FWD: 5'-
ATCCAGCTTGTCCCCAAAG-3'; REV: 5'-ATTTCAT-
TCGCTGGTTCTGG-3'; annealing temperature = 60°C,
expected product length = 438 bp). The Nanog primers
described in this report were designed based on new por-
cine sequence information (unpublished data) and
encompassed a large segment homologous to the coding
region of the human sequence. Primers for Oct-4 were
synthesized using a published primer sequence [29] that
was reported to span an intron (FWD: 5'-AGGTGT-
TCAGCCAAACGACC-3'; REV: 5'-TGATCGTTTGCCCT-
TCTGGC-3'; annealing temperature = 60°C). Product size
was estimated to be 335 bp, (see [29]). β-actin primers
were selected as a loading control (FWD: 5'-ATCTT-
GATCTTCATGGTGCTGGGC-3'; REV: 5'-ACCACT-
GGCATTGTCATGGACTCT-3'; annealing temperature =
60°C, expected product size = 545 bp) [30]. The reactions
were assembled using 200–800 ng of total RNA, 400 µM
dNTPs, 400 nM FWD and REV primers, 1 µl enzyme mix
and 5 µl buffer in a 25 µl reaction volume. The following
PCR protocol was performed: 30 min reverse transcription
step at 50–55°C, 15 min denature step at 95°C followed
by 35 cycles of 94°C for 30 sec, annealing step for 30 sec
and elongation at 72°C for 45 sec with a final extension
at 72°C for 10 min using a Techne Touchgene thermocy-
cler (Krackeler Scientific, Albany, NY). Reactions con-
ducted without reverse transcriptase were run in parallel
using ExTaq (TaKaRa, Otsu, Shiga, Japan) in place of the
OneStep RT-PCR enzyme mix. PCR products were
resolved in a 1% agarose gel containing 1 µg/ml ethidium
bromide. Images were captured on a FluorChem 8900
imaging system (Alpha Innotech, San Leandro, CA) and
processed for publication as described above.
Porcine embryonic disc, PUC cell, and porcine fibroblast
RNA was collected as described above and subjected to
quantitative RT-PCR using Nanog, Oct-4, Sox-2 and 18S
ribosomal subunit primers (18S primer sequences were as
follows: FWD: 5'-GAGGTTCGAAGACGATCAGA-3'; REV:
5'-TCGCTCCACCAACTAAGAAC-3'; annealing tempera-
ture = 55°C). In two separate experiments, RNA was col-
lected from three pooled porcine embryonic discs
(approximately 14 days postestrus), porcine fibroblasts
from a single pig, and two different PUC cell isolations. In
a third experiment, RNA was isolated from three pooled
embryonic discs (approximately 14 days postestrus), por-
cine fibroblasts from a single pig and one PUC isolation,
PUC cells isolated from Wharton's jelly explants form colo- nies Figure 1
PUC cells isolated from Wharton's jelly explants 
form colonies. Typical morphology of PUC cells after 1–2 
weeks in culture. Spindle-shaped PUC cells adhered to plastic 
growth plates and formed colonies of tightly-packed, small 
round cells. PUC cells have been maintained in culture for up 
to 14 passages without noticeable change. Bar = 200 µM.Reproductive Biology and Endocrinology 2006, 4:8 http://www.rbej.com/content/4/1/8
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all of which were collected from different pigs than the
first two experiments. RNA was quantified using an ND-
1000 spectrophotometer (NanoDrop Technologies,
Wilmington, DE) and diluted to nominally 10–200 ng/µl.
Quantitative reactions were assembled using a Qiagen
OneStep RT-PCR kit, 20, 200 or 800 ng of total RNA and
1× SYBR Green dye (Roche, Indianapolis, IN) in a 25 µl
reaction volume. PCR was conducted for 50 cycles with
SYBR Green fluorescence detected after each cycle. Reverse
transcription was omitted as a negative control by replac-
ing the Qiagen enzyme mix with ExTaq DNA polymerase
(TaKaRa). All other parameters were identical to non-
quantitative reactions (see protocol above). Reactions
were carried out on a SmartCycler system (Cepheid, Sun-
nyvale, CA). For data analysis, the Ct value (the cycle
number at which the fluorescence crosses the threshold)
for each of the three markers was normalized to 18S to
correct for minor variances in loading. The mRNA copy
number relative to fibroblasts was calculated by raising 2
to the power of the difference of embryonic disc or PUC
Ct value and fibroblast Ct value, providing a fold-differ-
ence to compare the relative expression levels.
Sequencing of PCR products was conducted by excising
the bands from the agarose gel and purifying the comple-
mentary DNA (cDNA) using a QIAquick PCR purification
kit (Qiagen). The purified cDNA was either sequenced at
the Kansas State University DNA Sequencing Facility, or
further processed for sequencing on a CEQ 8000 DNA
sequencer (Beckman Coulter, Fullerton, CA). Briefly, puri-
fied cDNA was resolved by gel electrophoresis, prepared
for analysis using a dye terminator cycle sequencing kit
(DTCS, Beckman Coulter), precipitated and suspended in
an appropriate sequencing buffer. The resulting sequences
were analyzed and aligned using the Basic Local Align-
ment Sequence Tool (BLAST) either to known GenBank
gene entries or to the porcine database in The Institute for
Genomic Research (TIGR). Alignment figures were created
using BOXHADE 3.21 http://www.ch.embnet.org/soft
ware/BOX_form.html.
Immunocytochemistry
PUC cells were seeded onto glass coverslips and allowed
to grow for up to 2 weeks. Porcine fibroblasts were simi-
larly seeded and cultured for up to 7 days prior to analysis.
Growth medium was removed and the cells were fixed in
4% paraformaldehyde for 5 min followed by permeation
with 0.2% Triton-X-100 (Fisher Chemicals; Fairlawn, NJ)
and blocked with an appropriate agent (3% normal goat
or donkey serum + 1% bovine serum albumin in PBS).
The primary antibodies used were goat anti-Oct-3/4
(Santa Cruz Biotechnology; Santa Cruz, CA; n = 3) diluted
1:50 or 1:100 in 0.5× blocking solution, or rabbit anti-
Nanog (Chemicon International; Temecula, CA; n = 5)
diluted 1:200 and applied for 1 hr at room temperature or
overnight at 4°C. Secondary antibodies (donkey anti-goat
IgG-FITC conjugated, diluted 1:200 in PBS (Jackson
ImmunoResearch Laboratories, West Grove, PA) or goat
anti-rabbit IgG-Alexa-488 conjugated, diluted 1:500 in
PBS (Molecular Probes, Eugene, OR)) were applied for 1
hour at room temperature. Cells were further counter-
stained with 4',6-diamidino-2-phenylindole (DAPI, Vec-
tor Laboratories, Burlingame, CA) and imaged on a Nikon
Eclipse 80i microscope fitted with a Photometrics Cool-
Snap ES digital camera using appropriate filters. Images
were captured with MetaMorph software (Molecular
Devices Corporation, Sunnyvale, CA) and processed for
publication using CorelDRAW and/or Paint Shop Pro
with identical settings for control and experimental slides.
Results
Morphological assessment and selection
Cells isolated from porcine umbilical cord matrix explants
were expanded in culture and displayed a heterogeneous
PUC cells selected for stem cell-like morphology Figure 2
PUC cells selected for stem cell-like morphology. The initial population of cells (passage zero, or P0; A) expanded from 
explants contain many different cell types based on morphology. After one passage (P1) using the described selection tech-
nique, the number of round and fibroblast-like cells was significantly increased (B) and was further enhanced after passage 2 
(C). Bar = 200 µM.Reproductive Biology and Endocrinology 2006, 4:8 http://www.rbej.com/content/4/1/8
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morphology with many spindle-shaped cells and small
round cells with a high nucleus to cytoplasm ratio. The
round cells often formed colonies or clusters after 1–2
weeks in culture (Fig. 1). In these studies, approximately
60% (27 of 45) of PUC cell isolations yielded colonies,
although all isolates yield cells of similar morphology.
Colonies appeared as tightly packed mounds or clusters of
small round cells and grew to as much as 0.5 mm in diam-
eter, although most were smaller (0.1–0.2 mm). The for-
mation of colonies was observed in PUC cells as late as
passage 14. Data presented in this report were obtained
from PUC isolations no later than passage 14.
The isolation of cells with stem cell-like morphology
(small, round cells and spindle-shaped cells) was
enhanced by selectively eliminating the population of
tightly adhered, apparently differentiated cells at the first
passage. This was accomplished by first removing any
remaining explanted tissue and incubating the remaining
cells in trypsin/EDTA for 3 min. Only the cells that
detached in this period of time were resuspended in
growth medium and seeded to the next flask. This method
was repeated for subsequent passages and increased the
proportion of cells with stem cell-like morphology as well
as their ability to form colonies (Fig. 2). Cells that
remained adhered to the flask at passage were large, flat
cells that produced few colonies as compared to the pas-
saged cells. These cells were ultimately discarded. All PUC
cell isolations providing data for this report were con-
ducted in this manner.
PUC colonies express alkaline phosphatase Figure 3
PUC colonies express alkaline phosphatase. Colony-forming PUC cell isolates stained for the presence of alkaline phos-
phatase. Staining was most intense in the colonies (A, C and D). Addition of 3–5 µM levamisole to the solution inhibited the 
staining (B). Usually, a small number of positive individual cells was also stained (arrows in C and D). Results are typical of 11 
separate experiments. Bars = 500 µM (A and B), 200 µM (C and D).Reproductive Biology and Endocrinology 2006, 4:8 http://www.rbej.com/content/4/1/8
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Alkaline phosphatase detection
The colonies formed by PUC cells in culture exhibited
alkaline phosphatase activity, which is consistent with
stem cell identity. PUC cells were maintained in culture
until colony formation was observed. The cells were then
incubated in the detection solution for 20 min and mon-
itored for the development of a blue reaction product
indicating alkaline phosphatase activity. The reaction
product was most intense within and surrounding the col-
onies (Fig. 3A, representative from 11 separate observa-
tions), although staining was observed in a small number
of individual cells (Fig. 3C and 3D). When levamisole was
included in the substrate, no reaction was observed (Fig.
3B).
Hoechst dye-exclusion and flow cytometry
As shown in Fig. 4A, flow cytometry revealed a population
of Hoechst dye-excluding PUC cells. A distinct population
of verapamil-sensitive, Hoechstlow cells were identified
based on low fluorescence intensity (about 50% of the
Hoechstlow cells, see Fig. 4B). Five paired experiments (±
verapamil) were conducted on four PUC cell isolations. In
the absence of verapamil, the percentage of Hoechstlow
cells was (mean ± SEM) 7.3% ± 1.9% with a range of 3.6–
12.7%. Incubation with 50 µM verapamil in conjunction
with the Hoechst dye significantly decreased the Hoechst-
low population to 3.9% ± 1.4% with a range of 1.9% to
9.5% (Fig. 4E). A reduction in the percentage of gated cells
was observed in every case in the presence of verapamil.
As a comparison, porcine fibroblasts were analyzed in a
separate experiment and the percent of Hoechstlow cells in
the absence and presence of verapamil was not different
and the percentage of Hoechstlow cells was less when com-
pared to PUC cells (e.g., 0.5% for fibroblasts, see Fig. 4C,
D).
RT-PCR detection and sequence analysis
Total RNA was isolated from porcine embryonic discs as a
positive control for the presence of the three early stem
cell markers. Single amplification products of expected
sizes were observed using embryonic disc RNA prepara-
tions and primers for Nanog, Oct-4 and Sox-2 (Fig. 5A). All
three transcription factor genes, Nanog, Oct-4 and Sox-2,
were also detected in PUC cells (Fig. 5B). Reactions omit-
ting the reverse transcriptase (-RT) using Nanog and Sox-2
primers produced no product. The Oct-4 primers spanned
PUC isolations contain a side population of verapamil-sensitive, Hoechst-dye excluding cells Figure 4
PUC isolations contain a side population of verapamil-sensitive, Hoechst-dye excluding cells. A side population of 
Hoechstlow cells in PUC cell isolations (A) was visible after using dual-filter flow cytometry, and was partially inhibited with the 
addition of 50 µM verapamil (B). The percent of cells that constituted the side population was in the gated regions. A vera-
pamil-sensitive side population was not observed in porcine fibroblasts (C and D). A summary of the side population with and 
without verapamil from four PUC cell isolations is in panel E.
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an intron, therefore the -RT condition was not included.
Primers for β-actin were included in most experiments as
a loading control. Reactions using Nanog, Oct-4 and Sox-2
primers were conducted 41, 46 and 23 times, respectively.
These also included primers for Nanog and Oct-4 that were
not described here, but further confirmed the presence of
these genes. The lower mobility band for Oct-4 was elim-
inated by increasing the temperature of the RT step to
55°C (not shown). The band of expected size (Oct-4, 335
bp) was processed for sequencing (see below).
Expression of the three transcription factors was also
detected in porcine fibroblasts that were isolated from a
3–4 month old pig (Fig. 5C). The multiple bands
observed in the Sox-2 lane in Fig. 5C were observed in 5
of 22 reactions using fibroblasts.
The sequence of Sox-2 PCR products employing RNA iso-
lated from PUC cells displayed 96% (388/401 bp) homol-
ogy to the human sequence [Genbank: NM_003106] and
97% (392/401 bp) homology to the ovine sequence
[GenBank: X96997] [see Additional file 2]. Analysis also
revealed >99% (400/401 bp) homology to a porcine EST
[TIGR: TC208722]. Nanog  primers produced a single
amplified product of expected size from PUC isolations
with 86% (326/379 bp) homology to a human Nanog
sequence [Genbank: AB093576] and a 268 bp segment
with 99% homology to the published Sus scrofa Nanog
partial sequence [GenBank: AY596464] [see Additional
file 1]. Oct-4 PCR amplified products from PUC isolations
displayed >99% (298/300) homology to the Sus scrofa
Oct-4 sequence [TIGR: TC205936] [see Additional file 3].
Immunocytochemistry
Immunocytochemical analysis was performed to test for
expression of Nanog and Oct-4 protein. Positive labeling
for Nanog in PUC cell nuclei (Fig. 6A) as well as lack of
signal when primary antibody was omitted (Fig. 6D),
strongly suggests the presence of Nanog protein. Superim-
position of images from antibody-treated cells and the
DAPI counterstain (Fig. 6B) reveal that virtually every cell
displayed nuclear Nanog immunoreactivity (Fig. 6C).
Faint cytoplasmic labeling was detected in some cells.
Cultured porcine fibroblasts were processed in parallel
and revealed very low fluorescence intensity (Fig. 6E).
Superimposition with the DAPI counterstain (Fig. 6F)
again revealed some cytoplasmic labeling (Fig. 6G). No
signal was detected in parallel experiments in which the
primary antibody was omitted (Fig. 6H). Experiments
were conducted five times.
Nuclear immunoreactivity for Oct-4 (Fig. 7A) was also
detected in virtually all PUC cells (2 of 3 isolations) when
compared with DAPI counterstain (Fig. 7B). Porcine
fibroblasts were consistently negative (in two separate
experiments, Fig. 7E). DAPI counterstain in Fig. 7F con-
firms the presence of cells. No fluorescence for Oct-4 was
observed in the absence of primary antibody in either cell
type (Fig. 7C and 7G), but DAPI counterstain again con-
firmed the presence of cells (Fig. 7D and 7H).
Quantitative RT-PCR
Quantitative RT-PCR was conducted to determine the rel-
ative expression levels of Nanog,  Oct-4  and  Sox-2  in
embryonic discs, PUC cells and porcine fibroblasts.
Results indicate that differences in the expression levels
were apparent between cell types (Fig. 8). Results from
one experiment using 200 ng of total RNA are presented
as representative data from three independent trials.
Nanog, Oct-4 and Sox-2 products are shown along with
18S ribosomal subunit RNA (an internal standard for
RNA loading). For Oct-4 and Sox-2, the embryonic disc
sample expressed the highest copy number of target RNA
(380 to 6400-fold, and 20 to 790-fold greater than fibrob-
lasts, respectively) followed by PUC cells (0.4 to 110-fold,
and 1.4 to 3.9-fold), when normalized to the expression
levels of fibroblasts. The copy number for Nanog RNA
ranged from 1.5 to 40-fold and 1.4 to 8.6-fold higher than
fibroblasts for embryonic disc and PUC cells, respectively.
Transcription factors Nanog, Oct-4 and Sox-2 present in por- cine tissue Figure 5
Transcription factors Nanog, Oct-4 and Sox-2 present 
in porcine tissue. Gene specific primers for Nanog (N), Oct-
4 (O) and Sox-2 (S) amplified single bands of 438, 335 and 443 
bp, respectively, in day 14–15 postestrus embryonic discs 
(A). Bands of expected sizes were also amplified in PUC cells 
(B) as well as in porcine fibroblasts (C). Reactions omitting 
the RT step produced no bands (-RT). As a loading positive 
control, β-actin primers (β) were included in most reactions.Reproductive Biology and Endocrinology 2006, 4:8 http://www.rbej.com/content/4/1/8
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Importantly, the results show that these stem cell markers
are expressed in greater copy number in PUC cells than in
porcine fibroblasts, although less than in porcine embry-
onic disc.
Discussion
Here we report expression of Nanog, Oct-4 and Sox-2 in
cultured PUC matrix cells. These transcription factors are
considered key regulators of gene transcription in primi-
tive stem cells. Quantitative RT-PCR revealed that PUC
cells and porcine embryonic discs express Nanog RNA at
higher levels than porcine fibroblasts. Both Oct-4 and Sox-
2 message was present in discs in substantially greater
amounts than in PUC cells, and PUC cells contained more
message than fibroblasts. Nanog, Oct-4, and Sox-2 have
been reported to occupy the promoters of at least 2,260
human genes and these transcription factors co-occupy
353 gene promoters [9]. Thus, these transcription factors
regulate pluripotency and self renewal both jointly and
individually in human ESCs. Similar data are not availa-
ble for the pig, but it is likely that these transcription fac-
tors regulate central events in stem cell renewal and
potency in this species.
We observed gene expression of RNA for all three tran-
scription factors in porcine embryonic discs, PUC cells,
and fibroblasts. Therefore, quantitative RT-PCR data on
the expression of these transcription factors was under-
taken. In particular, the high level of mRNA expression of
Nanog in both PUC cells and embryonic discs suggests
that the regulatory pathways influenced by Nanog in the
pig may be similarly activated or inactivated in the embry-
onic disc and PUC cells. However, the reduced expression
of Oct-4 and Sox-2 in PUC cells relative to the embryonic
disc could indicate that genes regulated by these transcrip-
tion factors may have different expression patterns in
these two tissues. Because genetic studies of the functions
of these transcription factors are not available in the pig,
the meaning of the lower expression of Oct-4 and Sox-2
mRNA in PUC cells is unknown. The significance of
expression, albeit at low levels, of all three transcription
factors in fibroblasts is also unclear but may indicate that
quantitative regulation is determinative of the differentia-
tion state in this species.
A recent paper described colony formation and Oct-4
expression in fetal murine and porcine fibroblasts, but
failed to replicate these findings in adult-derived porcine
fibroblasts [29]. Expression of Oct-4 in fetal fibroblasts
was only detected when the cells were maintained in 30%
calf serum, suggesting that some constituent of the serum
must be present in sufficient quantities for expression to
be seen. The growth medium used in the present study
contains only 2% FBS, although it is supplemented with
several other factors, including EGF and dexamethasone.
These differences in culture conditions may explain the
divergent results. Other differences in early gene expres-
sion between the pig and the mouse have also been noted.
Nanog protein detection in PUC isolations Figure 6
Nanog protein detection in PUC isolations. Nanog protein was found in the nuclei of PUC cells (n = 5) (A). Comparison 
to TO-PRO-3 nuclear counterstain (B) revealed positive staining in virtually every cell (see superimposed image in C), although 
faint labeling was detected in the cytoplasm of some cells (arrowheads). Superimposing primary antibody-omitted controls with 
the nuclear counterstain image revealed no protein detection (D). Nuclear labeling was detected, but reduced, in porcine 
fibroblasts (E). Superimposition of E with nuclear counterstain (F) with faint cytoplasmic labeling in some cells (G). Primary 
antibody-omitted control and nuclear counterstain revealed no labeling (H). Bar = 50 µM.Reproductive Biology and Endocrinology 2006, 4:8 http://www.rbej.com/content/4/1/8
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For example, Oct-4 is expressed in trophectoderm as well
as in the inner cell mass of the pig, but only the latter in
the mouse [31]. Other reports have suggested that Nanog
RNA is present in both the embryonic and extraembryonic
porcine conceptus tissues at day 15 of pregnancy [32].
The relative levels of mRNA expression for Nanog, Oct-4
and Sox-2 (as compared to fibroblasts) appears to vary in
embryonic discs and PUC cells with embryonic discs
clearly expressing more Oct-4 and Sox-2. Numerous fac-
tors may explain these results. First, PUC cells and fibrob-
lasts may contain stem cells with similar gene expression
levels to those present in embryonic discs, but have a
smaller stem cell to non-stem cell ratio than embryonic
discs. However, immunocytochemical analysis suggests
that while protein levels may differ in PUC cells and
fibroblasts, both cell types display nuclear labeling in a
uniform manner suggesting that all cells express (or do
not express) Nanog and Oct-4 protein at similar levels.
Alternatively, posttranslational modifications may
account for the reduced expression of Nanog protein and
lack of Oct-4 protein in porcine fibroblasts despite the
detection of mRNA for both genes. It is unknown whether
no protein or an alternative form of the protein is being
expressed in fibroblasts. Nonetheless, PUC cells express
Nanog, Sox-2 and Oct-4 at the mRNA level with nuclear
immunoreactivity for Nanog and Oct-4 being clearly and
uniformly present.
The expression of Nanog, Oct-4 and Sox-2 was detected by
RT-PCR in PUC cells. The amplification of these transcrip-
tion factors using RT-PCR techniques produced bands of
expected sizes for each PCR product. The subsequent
sequencing of the product and high homology to pub-
lished human and pig sequences is a strong indication of
the presence of these genes. Three separate quantitative
analysis experiments revealed higher mRNA expression
levels of Nanog  and  Sox-2  in PUC cells compared to
fibroblasts, while two out of three experiments revealed
higher levels of Oct-4 mRNA in PUC cells compared to
fibroblasts. Nuclear immunocytochemical labeling for
Oct-4 and Nanog support this result. Recent studies have
identified several processed pseudogenes for Nanog and
Oct-4 in the human and mouse genome, including two
that have been identified in expressed sequence tags
[33,34]. It is currently unknown whether similar pseudo-
genes exist in pigs and whether they are expressed. How-
ever, nuclear immunolabeling suggests the presence of
functional Nanog and Oct-4 protein in PUC cells.
Oct-4, Nanog and Sox-2 are central regulators for main-
taining a pluripotent state in mouse and human ESCs. In
the mouse, artificial Oct-4 upregulation results in differen-
tiation of ESCs into extraembryonic mesoderm or endo-
derm while Oct-4  knockout ESCs differentiate into
trophectoderm [35,36]. Upregulation of Nanog  allows
mouse ESCs to remain pluripotent without the need for
leukemia inhibitory factor (LIF) supplementation in the
growth medium [7,8]. Sox-2 is a regulatory transcription
factor expressed in early development in many tissues
including ESCs [6]. Gene expression was supported by
immunocytochemical detection of a Nanog epitope that
Oct-4 protein is present in PUC isolations Figure 7
Oct-4 protein is present in PUC isolations. Oct-4 detected in the nucleus of PUC cells (n = 3) (A). Faint cytoplasmic flu-
orescence was detected in some cells (arrowheads), this was not found in all PUC isolates. Nuclear counterstaining (B) 
revealed Oct-4 staining in virtually every cell when compared to A. No labeling was found when the primary antibody was 
omitted (C). Nuclear counterstain of control shows lack of nuclear Oct-4 staining (D). No label was seen in porcine fibroblasts 
(E) or in primary-omitted controls (G). The presence of cells was confirmed with nuclear counterstaining (H). Bar = 50 µM.Reproductive Biology and Endocrinology 2006, 4:8 http://www.rbej.com/content/4/1/8
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demonstrated nuclear labeling, consistent with transcrip-
tion factor localization. Oct-4 immunoreactivity in the
nucleus was also detected. In sum, these data suggest that
PUC matrix cells constitute a population of stem cells that
share some of the phenotypic characteristics of ESCs and
also of non-embryonic stem cell populations.
Alkaline phosphatase activity was observed in colony-
forming PUC isolations. Alkaline phosphatase is an
enzyme long-known to be expressed in ESCs as well as pri-
mordial germ cells [37]. The reaction product formed in
PUC cell cultures is most intense in and around the colo-
nies, similar to the pattern observed in ESC cultures and
other colony-forming stem cells. Alkaline phosphatase is
an enzyme expressed in many tissues and alone is not spe-
cific for stem cells. However, during development, pri-
mordial germ cells (which express alkaline phosphatase)
are formed in the yolk sac and migrate through the devel-
oping umbilical cord en route to their final destination in
the gonadal ridge. It is possible that some of these migrat-
ing germ cells or their descendents remain in the umbili-
cal cord matrix.
PUC cells displayed a Hoeschtlow side population that was
detected by flow cytometry. Hematopoietic stem cells
contain a small population of Hoechst dye-excluding cells
(termed side population or SP) when examined by flow
cytometry, and this property is inhibited in the presence
of verapamil [38,39]. Although verapamil is best known
as a calcium channel blocker, it is also used as an inhibitor
of P-glycoprotein, a member of the ATP-binding cassette
(ABC) transporter superfamily, which is found in hemat-
opoietic stem cells as well as cancer cells [39]. These side
population cells exhibit the greatest hematopoietic stem
cell activity in repopulation studies [38]. Typically, the
percentage of Hoechstlow cells in bone marrow samples is
less than 1% of the total population. Our observation of
approximately 7% (of which, 3% were verapamil sensi-
tive) suggests that a higher concentration of stem-like cells
are present in PUC cell isolations.
The present results are consistent with the interpretation
that PUC cells represent a stem cell population that
expresses the central regulators required for mouse embry-
onic stem cells. Transplantation studies will be required to
define the potential of PUC cells when placed in various
in vivo environments, but the characteristics identified
here suggest that PUC cells will have a wide potential.
We conclude that PUC matrix cells contain unique and
primitive cells whose potential is as yet undefined. Ease of
collection and propagation, and abundant numbers make
PUC matrix cells an attractive candidate as a resource for
stem cell biotechnology and biomedical research.
Additional material
Additional file 1
Sequence alignment of Nanog PCR products. Alignment of Nanog PCR 
product sequence from embryonic disc (Disc), porcine ear fibroblasts 
(Ear), PUC cells (PUC) and Sus scrofa Nanog gene exon 2 and partial 
coding sequence from GenBank (AY596464). Disc, Ear and PUC 
sequences share a 268 bp segment with 99% homology to the published 
Sus scrofa sequence.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1477-
7827-4-8-S1.jpeg]
Additional file 2
Sequence alignment of Sox-2 PCR products. Direct sequencing of 
embryonic disc (Day15_Disc) and PUC cells (PUC1) using Sox-2 prim-
ers were aligned to the human and ovine Sox-2 sequence. PUC sequence 
alignment revealed 96% homology to the human Sox-2 sequence and 
97% homology to the ovine sequence.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1477-
7827-4-8-S2.jpeg]
Quantitative RT-PCR for Nanog, Oct-4 and Sox-2 expression  in embryonic disc, PUC cells and fibroblasts Figure 8
Quantitative RT-PCR for Nanog, Oct-4 and Sox-2 
expression in embryonic disc, PUC cells and fibrob-
lasts. Known concentrations of total RNA from day 14–15 
embryonic discs (Disc, black line), early passage PUC cells 
(PUC, green line) and porcine fibroblasts (Fibro, red line) 
were subjected to quantitative RT-PCR using gene specific 
primers for Nanog, Oct-4, Sox-2 and 18S ribosomal subunit. 
200 ng template RNA from each reaction was used here. The 
cycle number is shown on the X-axis and log2 fluorescence is 
shown on the Y-axis. Horizontal line in each graph indicates 
the threshold.Reproductive Biology and Endocrinology 2006, 4:8 http://www.rbej.com/content/4/1/8
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